Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -33.37% is 49% above its 5-year average of -65.68%, near the high end of its 5-year range (-139.53%–-27.39%).
2.69% above its 12-month average of -34.29%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -27.39%.
OPERATING MARGIN
-33.37%
OPERATING MARGIN AVG TTM
-34.29%
OPERATING MARGIN AVG 3Y
-43.00%
OPERATING MARGIN AVG 5Y
-65.68%
OPERATING MARGIN AVG 10Y
-67.18%
OPERATING MARGIN AVG 15Y
-93.75%
OPERATING MARGIN AVG 20Y
-55.79%
CURRENT VS TTM AVG
+2.69%
CURRENT VS 3Y AVG
+22.40%
CURRENT VS 5Y AVG
+49.19%
CURRENT VS 10Y AVG
+50.33%
CURRENT VS 15Y AVG
+64.40%
CURRENT VS 20Y AVG
+40.19%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cytosorbents Corporation
Market Cap
$12.46M
Operating Margin
-33.37%
TTM Avg
-34.29%
3Y Avg
-43.00%
5Y Avg
-65.68%
Market Cap
$12.63M
Operating Margin
-1315.51%
TTM Avg
-120503.86%
3Y Avg
-60605.86%
5Y Avg
-40403.91%
Market Cap
$11.95M
Operating Margin
N/A
TTM Avg
-2960.13%
3Y Avg
-1713.73%
5Y Avg
-1142.49%
Market Cap
$13.34M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.41M
Operating Margin
-21.94%
TTM Avg
-34.04%
3Y Avg
-49.86%
5Y Avg
-59.16%
Market Cap
$13.55M
Operating Margin
-859.22%
TTM Avg
-477.88%
3Y Avg
-341.34%
5Y Avg
-316.87%
Market Cap
$11.01M
Operating Margin
-5652.38%
TTM Avg
-2826.19%
3Y Avg
-9617.03%
5Y Avg
-6411.35%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.46M | -33.37% | -34.29% | -43.00% | -65.68% |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | -1315.51% | -120503.86% | -60605.86% | -40403.91% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A | -2960.13% | -1713.73% | -1142.49% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -21.94% | -34.04% | -49.86% | -59.16% |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | -859.22% | -477.88% | -341.34% | -316.87% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | -5652.38% | -2826.19% | -9617.03% | -6411.35% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -293.46% | -272.89% | -2404.23% | -2129.99% |
Gross Margin
71.6%
Operating Margin
-33.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -27.39% |
| 2026-03-31 | -34.34% |
| 2025-12-31 | -41.96% |
| 2025-09-30 | -30.17% |
| 2025-06-30 | -37.59% |
| 2025-03-31 | -44.54% |
| 2024-12-31 | -44.21% |
| 2024-09-30 | -51.04% |
| 2024-06-30 | -40.38% |
| 2024-03-31 | -51.80% |
| 2023-12-31 | -131.20% |
| 2023-09-30 | -94.79% |
| 2023-06-30 | -69.62% |
| 2023-03-31 | -83.51% |
| 2022-12-31 | -67.69% |
| 2022-09-30 | -139.53% |
| 2022-06-30 | -98.37% |
| 2022-03-31 | -98.32% |
| 2021-12-31 | -88.68% |
| 2021-09-30 | -60.73% |
| 2021-06-30 | -43.33% |
| 2021-03-31 | -28.12% |
| 2020-12-31 | -22.03% |
| 2020-09-30 | -19.13% |
| 2020-06-30 | -34.64% |
| 2020-03-31 | -30.39% |
| 2019-12-31 | -82.16% |
| 2019-09-30 | -98.25% |
| 2019-06-30 | -62.05% |
| 2019-03-31 | -93.62% |
| 2018-12-31 | -102.08% |
| 2018-09-30 | -53.13% |
| 2018-06-30 | -79.83% |
| 2018-03-31 | -69.95% |
| 2017-12-31 | -88.57% |
| 2017-09-30 | -62.31% |
| 2017-06-30 | -76.65% |
| 2017-03-31 | -59.98% |
| 2016-12-31 | -174.89% |
| 2016-09-30 | -100.05% |
| 2016-06-30 | -145.01% |
| 2016-03-31 | -130.87% |
| 2015-12-31 | -178.01% |
| 2015-09-30 | -200.75% |
| 2015-06-30 | -283.95% |
| 2015-03-31 | -321.22% |
| 2014-12-31 | -349.68% |
| 2014-09-30 | -163.06% |
| 2014-06-30 | -207.74% |
| 2014-03-31 | -202.13% |
| 2013-12-31 | -319.58% |
| 2013-09-30 | -432.30% |
| 2013-06-30 | -1099.49% |
| 2013-03-31 | -807.50% |
| 2012-12-31 | 138.50% |
| 2012-09-30 | -99.28% |
| 2012-06-30 | -3056.72% |
| 2012-03-31 | -6316.23% |
| 2011-12-31 | -2683.08% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 21785.28% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-02-28 | -238.82% |
| 2005-11-30 | -149.53% |
| 2005-08-31 | -247.36% |
| 2005-05-31 | 0.00% |
| 2005-02-28 | 0.00% |
| 2004-11-30 | 0.00% |
